3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Completed
2
Withdrawn
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
45
Recurrence
14
Lymphoma
6
Neoplasms
5
Neoplasms, Plasma Cell
4
Lymphoma, Large B-Cell, Diffuse
4
Waldenstrom Macroglobulinemia
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Lung Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Immunoglobulin Light-chain Amyloidosis
2
Hodgkin Disease
2
Glioblastoma
2
Amyloidosis
2
Wilms Tumor
1
Vomiting
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Ototoxicity
1
Osteosarcoma
1
Obesity
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Interventions
selinexor
1
XENP 1595
1
Tablets
1
Electroencephalography
1
Donepezil
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Alzheimer Disease
×
Dexamethasone
×
Clear all
NCT04984330
2022-11-17
STARR
Weill Medical College of Cornell University
Phase EARLY_PHASE1
Withdrawn